{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-016854","form_type":"8-K","ticker":"RKDA","cik":"0001469443","company_name":"Arcadia Biosciences, Inc.","filed_at":"2022-08-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.852820+00:00","generated_at":"2026-06-24T00:45:56.382408+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Arcadia Q2 revenue surges 175% to $3.9M; net loss improves to $0.17/share","bullets":["Q2 revenue $3.9M vs $1.4M a year ago, driven by Zola and GoodWheat pasta launch.","Net loss attributable to common stockholders narrowed 28% to $3.8M ($0.17 per share) from $5.3M.","First-half 2022 revenue $7.1M, up 217%; net loss $8.3M vs $3.2M, impacted by absence of $10.2M gain on Bioceres stock in 2021.","Received $2M milestone from Bioceres for HB4 soybean approval in China; part recognized as license revenue.","Introduced Project Greenfield, a 3-year plan aiming for profitability, focusing on core brands."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-016854","json":"https://secwatch.observer/filing/0000950170-22-016854.json","markdown":"https://secwatch.observer/filing/0000950170-22-016854.md","text":"https://secwatch.observer/filing/0000950170-22-016854.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1469443/000095017022016854/0000950170-22-016854-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1469443/000095017022016854/rkda-20220811.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T00:45:56.382408+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}